Withania somnifera Alleviates Parkinsonian Phenotypes by Inhibiting Apoptotic Pathways in Dopaminergic Neurons (original) (raw)

References

  1. Blum D, Torch S, Lambeng N, Nissou M, Benabid L, Sadoul R, Verna JM (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog Neurobiol 65:135–172
    Article CAS PubMed Google Scholar
  2. Simunovic F, Yi M, Wang Y, Macey L, Brown LT, Krichevsky AM, Andersen SL, Stephens RM, Benes FM, Sonntag KC (2009) Gene expression profiling of substantia nigra dopamine neurons, further insights into Parkinson’s disease pathology. Brain 132:1795–1809
    Article PubMed Central PubMed Google Scholar
  3. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415–455
    Article CAS PubMed Google Scholar
  4. Yadav S, Dixit A, Agrawal S, Singh A, Srivastava G, Singh AK, Srivastava PK, Prakash O, Singh MP (2012) Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson’s disease pathogenesis. Mol Neurobiol 829:1–8
    Google Scholar
  5. Prakash J, Yadav SK, Chouhan S, Singh SP (2013) Neuroprotective role of Withania somnifera root extract in Maneb–Paraquat induced mouse model of parkinsonism. Neurochem Res 38:972–980
    Article CAS PubMed Google Scholar
  6. Rajasankara S, Manivasagam T, Sankar V, Prakash S, Muthusamy R, Krishnamurti A, Surendran S (2009) Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson’s disease model mouse. J Ethnopharmacol 125:369–373
    Article Google Scholar
  7. Somayajulu-Niţu M, Sandhu JK, Cohen J, Sikorska M, Sridhar TS, Matei A, Borowy-Borowski H, Pandey S (2009) Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water soluble formulation of coenzyme Q10. BMC Neurosci 10:1–12
    Article Google Scholar
  8. Srivastava G, Dixit A, Yadav S, Patel DK, Prakash O, Singh MP (2012) Resveratrol potentiates cytochrome P4502d22-mediated neuroprotection in maneb- and paraquat-induced Parkinsonism in the mouse. Free Radic Biol Med 52:1294–1306
    Article CAS PubMed Google Scholar
  9. Pezzoli G, Cereda E (2013) Exposure to pesticides or solvents and risk of Parkinson disease. Neurology 80:2035–2041
    Article CAS PubMed Google Scholar
  10. Singhal NK, Chauhan AK, Jain SK, Shanker R, Singh C, Singh MP (2013) Silymarin and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism. Mol Cell Biochem 384:47–58
    Article CAS PubMed Google Scholar
  11. Xu D, Duan H, Zhang Z, Cui W, Wang L, Sun Y, Lang M, Hoi PM, Han Y, Wang Y, Lee SM (2013) The novel TetramethylpyrazineBis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis. J Neuroimmune Pharmacol 9:245–258
    Article Google Scholar
  12. Alam N, Hossain M, Khalil MI, Moniruzzaman M, Sulaiman SA, Gan SH (2012) Recent advances in elucidating the biological properties of Withania somnifera and its potential role in health benefit. Phytochemistry 11:97–112
    Article CAS Google Scholar
  13. Orru A, Marchese G, Casu G, Casu MA, Kasture S, Cottiglia F, Acquas E, Mascia MP, Anzani N, Ruiu S (2013) Withania somnifera root extract prolongs analgesia and suppresses hyperalgesia in mice treated with morphine. Phytomedicine 21:745–752
    Article PubMed Google Scholar
  14. Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, Komatsu K (2002) Axon or dendrite predominant outgrowth induced by constituents from Ashwagandha. Neuroreport 13:1715–1720
    Article CAS PubMed Google Scholar
  15. Tohda C, Joyashiki E (2009) Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor RET. Br J Pharmacol 157:1427–1440
    Article CAS PubMed Central PubMed Google Scholar
  16. Dhuley JN (1997) Effect of some Indian herbs on macrophage functions in ochratoxin A treated mice. J Ethnopharmacol 58:15–20
    Article CAS PubMed Google Scholar
  17. Chaurasia SS, Panda S, Kar A (2000) Withania somnifera root extract in the regulation of lead-induced oxidative damage in male mouse. Pharmacol Res 44:663–666
    Article Google Scholar
  18. Singh S, Singh K, Patel DK, Singh C, Nath C, Singh VK, Singh RK, Singh MP (2009) The expression of CYP2D22 an ortholog of human CYP2D6 in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson’s disease phenotype and nicotine mediated neuroprotection. Rejuvenation Res 12:185–197
    Article CAS PubMed Google Scholar
  19. Chaurasiya ND, Uniyal GC, Lal P, Misra L, Sangwan NL, Tuli R, Sangwan RS (2008) Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection. Phytochem Anal 19:148–154
    Article PubMed Google Scholar
  20. Tiwari MN, Singh AK, Ahmad I, Upadhyay G, Singh D, Patel DK, Singh C, Prakash O, Singh MP (2010) Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system. Free Radic Res 44:1416–1424
    Article CAS PubMed Google Scholar
  21. Martin PY, Bianchi M, Roger F, Niksic L, Féraille E (2002) Arginine vasopressin modulates expression of neuronal NOS in rat renal medulla. Am J Physiol Renal Physiol 283:559–568
    Google Scholar
  22. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
    Article CAS PubMed Google Scholar
  23. Gupta SP, Patel S, Yadav S, Singh AK, Singh S, Singh MP (2010) Involvement of nitric oxide in maneb and paraquat-induced Parkinson’s disease phenotype in mouse: is there any link with lipid peroxidation. Neurochem Res 35:1206–1213
    Article CAS PubMed Google Scholar
  24. Kasture S, Pontis S, Pinna A, Schintu N, Spina L, Longoni R, Simola N, Ballero M, Morelli M (2009) Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson’s disease. Neurotox Res 15:111–122
    Article PubMed Google Scholar
  25. Yadav SK, Prakash J, Chouhan S, Westfall S, Verma M, Singh TD, Singh SP (2014) Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model. Neurochem Int 65:1–13
    Article CAS PubMed Google Scholar
  26. Mochizuki H, Hayakawa H, Migit M, Shibata M, Tanaka R, Suzuki A, Shimo NY, Urabe T, Yamada M, Tamayos K, Shimada T, Miura M, Mizuno Y (2001) An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson’s disease. Proc Natl Acad Sci USA 98:10918–10923
    Article CAS PubMed Central PubMed Google Scholar
  27. Agrawal R, Tyagi E, Saxena G, Nath C (2009) Cholinergic influence on memory stages A study on scopolamine amnesic mice. Indian J Pharmacol 41:192–196
    Article PubMed Central PubMed Google Scholar
  28. Widodo N, Kaur K, Shrestha BG, Takagi Y, Ishii T, Wadhwa R, Kaul SC (2007) Selective killing of cancer cells by leaf extract of Ashwagandha Identification of a tumor inhibitory factor and the first molecular insights to its effect. Clin Cancer Res 13:2298–2306
    Article CAS PubMed Google Scholar
  29. Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC (1997) Environmental risk factors and Parkinson’s disease, a case-control study in Taiwan. Neurology 48:1583–1591
    Article CAS PubMed Google Scholar
  30. Willis AW (2013) Parkinson disease in the elderly adult. Mo Med 110:406–410
    PubMed Google Scholar
  31. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson’s disease. Histol Histopathol 12:25–31
    CAS PubMed Google Scholar
  32. Kingsbury AE, Mardsen CD, Foster OJ (1998) DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov Disord 13:877–884
    Article CAS PubMed Google Scholar
  33. Levy OA, Malagelada C, Greene LA (2009) Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps. Apoptosis 14:478–500
    Article PubMed Central PubMed Google Scholar
  34. Schwarting RK, Bonatz AE, Carey RJ, Huston JP (1991) Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections. Brain Res 554:46–55
    Article CAS PubMed Google Scholar
  35. Konar A, Shah N, Singh R, Saxena N, Kaul SC, Wadhwa R, Thakur MK (2011) Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One 6:1–11
    Article Google Scholar
  36. Jinsmaa Y, Florang VR, Rees JN, Anderson DG, Strac S, Doorn JA (2009) Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate. Chem Res Toxicol 22:835–841
    Article CAS PubMed Central PubMed Google Scholar
  37. Marchitti SA, Deitrich RA, Vasiliou V (2007) Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol Rev 59:125–150
    Article CAS PubMed Google Scholar
  38. Hinterberger H (1971) The biochemistry of catecholamines in relation to Parkinson’s disease. Aust N Z J Med Suppl 1:8–14
    Article Google Scholar
  39. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Costa D, Perry RH, Perry EK (1999) Dopaminergic activities in the human striatum rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Neuroscience 90:433–445
    Article CAS PubMed Google Scholar
  40. Yang L, Matthews RT, Schulz JB, Klockgether T, Liao AW, Martinou JC, Penney JB Jr, Hyman BT, Beal MF (1998) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice over expressing Bcl-2. J Neurosci 18:8145–8152
    CAS PubMed Google Scholar
  41. Bus JS, Gibson JE (1984) Paraquat: model for oxidant-initiated toxicity. Environ Health Perspect 55:37–46
    Article CAS PubMed Central PubMed Google Scholar
  42. Cohen GM, d’Arcy Doherty M (1987) Free radical mediated cell toxicity by redox cycling chemicals. Br J Cancer Suppl 8:46–52
    CAS PubMed Central PubMed Google Scholar
  43. Rappold PM, Tieu K (2010) Astrocytes and therapeutics for Parkinson’s disease. Neurotherapeutics 7:413–423
    Article CAS PubMed Central PubMed Google Scholar
  44. Mena MA, García de Yébenes J (2008) Glial cells as players in parkinsonism: the “good” the “bad” and the “mysterious” glia. Neuroscientist 14:544–560
    Article CAS PubMed Google Scholar
  45. Heneka MT, Rodríguez JJ, Verkhratsky A (2010) Neuroglia in neurodegeneration. Brain Res Rev 63:189–211
    Article CAS PubMed Google Scholar
  46. Jukkola P, Guerrero T, Gray V, Gu C (2013) Astrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity. Acta Neuropathol Commun 23:1–10
    Google Scholar

Download references